Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00635791
Show Display Options
Download search resultsDownload the search results for:
NCT00635791 (1 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Phase I Study of Vorinostat and Sorafenib in Advanced Cancer
Conditions: Malignant Solid Tumour;   Renal Cell Carcinoma;   Non Small Cell Lung Carcinoma
Interventions: Drug: Sorafenib;   Drug: Vorinostat

Indicates status has not been verified in more than two years